Arbutus Biopharma Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-57.9M | $-61.9M | $4.0M | — |
| FY2017 | $-48.6M | $-55.9M | $7.3M | $15.1M |
| FY2018 | $-67.9M | $-69.0M | $1.1M | $6.2M |
| FY2019 | $-71.0M | $-71.6M | $589.0K | $6.8M |
| FY2020 | $-51.4M | $-51.7M | $229.0K | $6.2M |
| FY2021 | $-67.5M | $-68.3M | $809.0K | $6.4M |
| FY2022 | $-35.4M | $-35.9M | $512.0K | $7.2M |
| FY2023 | $-85.9M | $-86.9M | $1.0M | $9.3M |
| FY2024 | $-64.9M | $-65.0M | $182.0K | $9.0M |
| FY2025 | $-39.6M | $-39.6M | $0 | $7.0M |